Towards Innovative Design and Application of Recombinant as a Vaccine Vector.

Efficient delivery of antigenic cargo to trigger protective immune responses is critical to the success of vaccination. Genetically engineered microorganisms, including virus, bacteria, and protozoa, can be modified to carry and deliver heterologous antigens to the host immune system. The biological vectors can induce a broad range of immune responses and enhance heterologous antigen-specific immunological outcomes. The protozoan genus is widespread in domestic animals, causing serious coccidiosis. parasites with strong immunogenicity are potent coccidiosis vaccine candidates and offer a valuable model of live vaccines against infectious diseases in animals. parasites can also function as a vaccine vector. Herein, we review recent advances in design and application of recombinant as a vaccine vector, which has been a topic of ongoing research in our laboratory. By recapitulating the establishment of an transfection platform and its application, it will help lay the foundation for the future development of effective parasite-based vaccine delivery vectors and beyond.